BED Calculator (Biologically Effective Dose)
Calculate the Biologically Effective Dose (BED) and Equivalent Dose in 2-Gy Fractions (EQD2) for radiation therapy treatment planning using the linear-quadratic model.
Quick presets for common tissue types:
Results
Table of Contents
What is the Biologically Effective Dose?
The Biologically Effective Dose (BED) is a concept in radiation oncology that quantifies the true biological effect of a radiation therapy regimen on tissue. Unlike the total physical dose (measured in Gray), BED accounts for the fact that the same total dose delivered in different fractionation schedules produces different biological effects.
BED was introduced to solve a fundamental problem in radiotherapy: when comparing different treatment protocols with different fraction sizes and numbers, the physical dose alone does not accurately predict the biological response. BED provides a standardized way to compare the biological effectiveness of different schedules.
For example, 60 Gy delivered in 30 fractions of 2 Gy has a different biological effect than 60 Gy delivered in 20 fractions of 3 Gy, even though the total physical dose is the same. The BED captures this difference mathematically.
The Linear-Quadratic Model
BED is derived from the linear-quadratic (LQ) model of cell survival, which describes how radiation damages DNA through two mechanisms:
- Linear component (α): Single-track damage — a single radiation event causes a lethal double-strand break. This component is proportional to dose (d) and dominates at low doses.
- Quadratic component (β): Two-track damage — two independent radiation events each cause single-strand breaks on opposite strands that together create a lethal lesion. This component is proportional to dose squared (d²) and becomes more significant at higher doses per fraction.
The cell survival fraction is described by:
The ratio α/β (in Gy) is a tissue-specific parameter that determines the sensitivity of tissue to changes in fraction size. It represents the dose at which linear and quadratic components of cell killing are equal.
BED Formula Explained
The BED is calculated using:
Where:
- n = number of fractions
- d = dose per fraction (Gy)
- α/β = tissue-specific radiosensitivity ratio (Gy)
This can also be written as:
Where D = n × d is the total physical dose. The term (1 + d/(α/β)) is called the relative effectiveness (RE) factor.
The EQD2 Calculator
The EQD2 (Equivalent Dose in 2 Gy fractions) converts any fractionation schedule to the equivalent total dose that would produce the same biological effect if delivered in conventional 2 Gy fractions:
Or equivalently:
EQD2 = D × (d + α/β) / (2 + α/β)
EQD2 is extremely useful because most historical clinical data and dose-response relationships are based on 2 Gy per fraction regimens. Converting to EQD2 allows direct comparison with this established evidence base.
α/β Ratio for Different Tissues
| Tissue Type | α/β Ratio (Gy) | Characteristics |
|---|---|---|
| Early-responding tissues (most tumors) | ~10 Gy | High proliferation rate, less sensitive to fraction size |
| Late-responding tissues (normal organs) | ~3 Gy | Slow turnover, more sensitive to fraction size changes |
| Prostate cancer | ~1.5 Gy | Unusually low for a tumor — behaves like late-responding tissue |
| Breast cancer | ~4 Gy | Intermediate, lower than classic 10 Gy assumption |
| Head & neck cancers | ~10 Gy | Typical early-responding tumor |
| Melanoma | ~0.6–2.5 Gy | Very low, benefits from hypofractionation |
| Spinal cord | ~2 Gy | Critical late-responding structure |
| Lung (late effects) | ~3 Gy | Late-responding normal tissue |
Clinical Use in Radiotherapy
BED and EQD2 are used daily in radiation oncology for:
- Comparing treatment protocols: Evaluating whether a new hypofractionated schedule is equivalent to a conventional regimen
- Treatment planning: Designing alternative fractionation schemes that are biologically equivalent
- Re-irradiation decisions: Calculating cumulative biological dose when a patient requires retreatment
- SBRT/SRS planning: Stereotactic body/brain radiotherapy uses large doses per fraction, making BED essential for dose assessment
- Brachytherapy: Comparing different dose rate and fractionation options in interstitial or intracavitary treatments
Fractionation Schedules
Conventional Fractionation
1.8–2.0 Gy per fraction, 5 days/week, over 6–7 weeks. This is the historical standard and the reference for EQD2 calculations.
Hypofractionation
Larger doses per fraction (>2 Gy), fewer total fractions. Examples include breast cancer (40 Gy in 15 fractions) and prostate cancer (60 Gy in 20 fractions). BED calculations ensure biological equivalence.
Hyperfractionation
Smaller doses per fraction (<1.8 Gy), more fractions, often given twice daily. Used in some head and neck protocols to reduce late effects.
SBRT (Stereotactic Body Radiotherapy)
Very large doses per fraction (6–24 Gy), 1–5 fractions total. Used for early-stage lung cancer, liver metastases, spine tumors. The LQ model's validity at these high doses is debated but BED remains commonly used.
Worked Examples
Example 1: Standard Lung Cancer Treatment
Regimen: 60 Gy in 30 fractions (2 Gy/fraction), α/β = 10 Gy
EQD2 = 72 / (1 + 2/10) = 72/1.2 = 60 Gy
As expected, a 2 Gy/fraction regimen gives EQD2 equal to the physical dose.
Example 2: Hypofractionated Breast
Regimen: 40 Gy in 15 fractions (2.67 Gy/fraction), α/β = 4 Gy
EQD2 = 66.7 / (1 + 2/4) = 66.7/1.5 = 44.5 Gy
Example 3: Prostate SBRT
Regimen: 36.25 Gy in 5 fractions (7.25 Gy/fraction), α/β = 1.5 Gy
EQD2 = 211.5 / (1 + 2/1.5) = 211.5/2.333 = 90.6 Gy
Frequently Asked Questions
What does the subscript in BED mean (e.g., Gy₁₀)?
The subscript indicates the α/β ratio used. BED₁₀ means the BED was calculated with α/β = 10 Gy (typically for tumors), while BED₃ uses α/β = 3 Gy (for late-responding normal tissues). Always specify the α/β used.
Is BED the same as tumor control probability?
No. BED is a dose metric, not a probability. However, higher BED generally correlates with higher tumor control probability. The relationship between BED and tumor control depends on additional factors like tumor volume, hypoxia, and repopulation.
Can I use BED for very large fraction sizes (SBRT)?
This is debated. The LQ model may overestimate cell killing at very high doses per fraction (>10 Gy). Some researchers use modified models (e.g., the universal survival curve or generalized LQ model) for SBRT doses. However, BED remains widely used in clinical practice even for SBRT.
Why is EQD2 so important?
Most of our clinical experience and dose-toxicity data come from decades of treatment with 2 Gy fractions. EQD2 translates any novel schedule into this common reference frame, enabling direct comparison with established outcomes data and dose constraints for normal organs.